Literature DB >> 21532569

A sponsor's experience with the Voluntary Harmonization Procedure for clinical trial applications in the European Union.

Georgios Amexis, Elmar Schmitt.   

Abstract

Mesh：

Year:  2011        PMID： 21532569     DOI： 10.1038/nrd3202-c1

Source DB:  PubMed          Journal:  Nat Rev Drug Discov        ISSN： 1474-1776            Impact factor:   84.694


× No keyword cloud information.
  1 in total

1.  Hartmut krafft. Interview by Bethan Hughes.

Authors:  Hartmut Krafft
Journal:  Nat Rev Drug Discov       Date:  2010-05-14       Impact factor: 84.694
  1 in total
  2 in total

1.  Experience and further development with the Voluntary Harmonization Procedure for multinational clinical trials in the European Union.

Authors:  Hartmut Krafft; Chantal Bélorgey; Gudrun Szalay
Journal:  Nat Rev Drug Discov       Date:  2012-05       Impact factor: 84.694

2.  Identifying obstacles hindering the conduct of academic-sponsored trials for drug repurposing on rare-diseases: an analysis of six use cases.

Authors:  Marta Del Álamo; Christoph Bührer; Dirk Fisher; Matthias Griese; Paul Lingor; Giovanni Palladini; Nicolas Sireau; Virginie Hivert; Luca Sangiorgi; Florence Guillot; Juliane Halftermeyer; Lenka Soucková; Kristýna Nosková; Regina Demlová
Journal:  Trials       Date:  2022-09-15       Impact factor: 2.728
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.